Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer

Clinical trial NCT00069160 · COMPLETED

Trial details

NCT number: NCT00069160
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Neoplasms Ovarian Neoplasms Cervix Neoplasms Renal Neoplasms

Start date: 2003-09-01
Primary completion: 2009-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.